Mining And Validating The Expression Pattern And Prognostic Value Of Acetylcholine Receptors In Non-Small Cell Lung Cancer

Guoyuan Ma,Delin Ji,Xiao Qu,Shaorui Liu,Xudong Yang,Guanghui Wang,Qi Liu,Jiajun Du
DOI: https://doi.org/10.1097/MD.0000000000015555
IF: 1.6
2019-01-01
Medicine
Abstract:Acetylcholine receptors (AChRs), including nicotinic acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors (mAChRs), are highly expressed in bronchial epithelial cells.We used The Cancer Genome Atlas (TCGA) data set to evaluate the expression pattern and prognostic value of the AChR gene family in non-small cell lung cancer (NSCLC). The mined data was validated by quantitative real-time polymerase chain reaction (qRTPCR) and immunohistochemistry (IHC).The survival analysis of TCGA data set showed that only CHRNA7 in the AChR gene family affected prognosis in both lung adenocarcinoma and lung squamous cell carcinoma. Furthermore, qRT-PCR proved that CHRNA7 was significantly upregulated in tumor tissues compared with matched normal tissues at mRNA level (P=. 001). The expression level of alpha 7 nAChR (encoded by CHRNA7) in 141 patients was measured by IHC and a high expression of alpha 7 nAChR was associated with unfavorable prognosis (P=. 008). Multivariate analysis showed that alpha 7 nAChR was an independent prognostic factor (HR= 2.041; 95% CI 1.188-3.506; P=. 007).alpha 7 nAChR was upregulated in NSCLC and was associated with unfavorable prognosis. This gene may be a potential target for lung cancer treatment.
What problem does this paper attempt to address?